blaNDM-5-Bearing IncFII-Type Plasmids of Klebsiella pneumoniae Sequence Type 147 Transmitted by Cross-Border Transfer of a Patient

Antimicrobial Agents and Chemotherapy
Juyoun ShinKwan Soo Ko

Abstract

The two plasmids extracted from Klebsiella pneumoniae sequence type 147 (ST147) isolates were analyzed. The first isolate was obtained from a patient transferred from United Arab Emirates to South Korea. The second isolate was obtained from a Korean patient and was suspected to be transmitted from the first patient. Sequences of two plasmids were almost the same, and genetic structures, including blaNDM-5, of these plasmids were similar to plasmids of NDM-1-producing Escherichia coli ST131 isolates found in Europe.

References

May 6, 2011·The Journal of Antimicrobial Chemotherapy·Panagiota GiakkoupiAlkiviadis C Vatopoulos
Apr 19, 2012·PloS One·Rémy A BonninPatrice Nordmann
Oct 20, 2012·Veterinary Microbiology·P L HoK H Chow
Nov 1, 2013·Journal of Medical Microbiology·So Yeon KimKwan Soo Ko
Nov 6, 2013·Emerging Infectious Diseases·Guiqing WangGary P Wormser
Jul 2, 2014·Antimicrobial Agents and Chemotherapy·Asma SassiJean-Marc Rolain
Sep 24, 2014·Antimicrobial Agents and Chemotherapy·Ryuichi NakanoYasuo Ono
Sep 24, 2014·Antimicrobial Agents and Chemotherapy·Ping YangZhiyong Zong
May 20, 2015·Emerging Infectious Diseases·Sun Young ChoJae-Hoon Song
Jul 15, 2015·Antimicrobial Agents and Chemotherapy·Basudha ShresthaBharat M Pokhrel

❮ Previous
Next ❯

Citations

Mar 28, 2017·Diagnostic Microbiology and Infectious Disease·Hella LahlaouiThierry Naas
Dec 14, 2017·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Anaïs PotronLaurent Dortet
Mar 22, 2020·Applied and Environmental Microbiology·Dewa A P Rasmika DewiTorsten Thomas
Apr 11, 2020·Diagnostic Microbiology and Infectious Disease·So Yeon KimKwan Soo Ko
Jul 20, 2021·The Journal of Antimicrobial Chemotherapy·Haejeong Lee, Kwan Soo Ko

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Department of State Publication. Background Notes Series
United States. Department of State. Bureau of Public Affairs
Transplantation Proceedings
M A MasriA Pingle
Emerging Infectious Diseases
Annarita MazzariolGiuseppe Cornaglia
© 2021 Meta ULC. All rights reserved